Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-05 @ 11:29 AM
Last Modification Date: 2025-12-17 @ 3:54 PM
Study NCT ID: NCT00057720
Protocol Section: NCT00057720
Start Identification Module Data
Brief Title: TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
Official Title: Phase 3 Randomized Study of TLK286 (Telcyta) Versus Doxil/Caelyx or Hycamtin as Third-Line Therapy in Platinum Refractory or Resistant Ovarian Cancer [ASSIST-1 (Assessment of Survival In Solid Tumors-1)]
Acronym: None
Organization: Telik
Organization Class: INDUSTRY
Organization Study ID: TLK286.3017
Start Status Module Data
Status Verified Date: 2006-05
Overall Status: None
Study First Submit Date: 2003-04-07
Study First Submit QC Date:
Last Update Submit Date: 2011-07-21
Status: COMPLETED
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Telik
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Telik
Start Oversight Module Data 6268
Description Module: 8968
Study Last Update Post Date Type(Status Module):
Attachment: Upload